1208 related articles for article (PubMed ID: 29146134)
21. Sulfonamide bearing pyrazolylpyrazolines as potent inhibitors of carbonic anhydrase isoforms I, II, IX and XII.
Khloya P; Ceruso M; Ram S; Supuran CT; Sharma PK
Bioorg Med Chem Lett; 2015 Aug; 25(16):3208-12. PubMed ID: 26105196
[TBL] [Abstract][Full Text] [Related]
22. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties.
Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
Bioorg Med Chem Lett; 2004 Nov; 14(21):5427-33. PubMed ID: 15454239
[TBL] [Abstract][Full Text] [Related]
23. Design and synthesis of novel benzenesulfonamide containing 1,2,3-triazoles as potent human carbonic anhydrase isoforms I, II, IV and IX inhibitors.
Kumar R; Vats L; Bua S; Supuran CT; Sharma PK
Eur J Med Chem; 2018 Jul; 155():545-551. PubMed ID: 29909339
[TBL] [Abstract][Full Text] [Related]
24. Biological evaluation, radiosensitizing activity and structural insights of novel halogenated quinazoline-sulfonamide conjugates as selective human carbonic anhydrases IX/XII inhibitors.
Ghorab MM; Soliman AM; Bua S; Supuran CT
Bioorg Chem; 2021 Feb; 107():104618. PubMed ID: 33485104
[TBL] [Abstract][Full Text] [Related]
25. New anticancer drug candidates sulfonamides as selective hCA IX or hCA XII inhibitors.
Gul HI; Yamali C; Sakagami H; Angeli A; Leitans J; Kazaks A; Tars K; Ozgun DO; Supuran CT
Bioorg Chem; 2018 Apr; 77():411-419. PubMed ID: 29427856
[TBL] [Abstract][Full Text] [Related]
26. Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes.
Puccetti L; Fasolis G; Vullo D; Chohan ZH; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 Jun; 15(12):3096-101. PubMed ID: 15908204
[TBL] [Abstract][Full Text] [Related]
27. N-β-glycosyl sulfamides are selective inhibitors of the cancer associated carbonic anhydrase isoforms IX and XII.
Rodríguez OM; Maresca A; Témpera CA; Bravo RD; Colinas PA; Supuran CT
Bioorg Med Chem Lett; 2011 Aug; 21(15):4447-50. PubMed ID: 21723123
[TBL] [Abstract][Full Text] [Related]
28. Novel Re(I) tricarbonyl coordination compounds based on 2-pyridyl-1,2,3-triazole derivatives bearing a 4-amino-substituted benzenesulfonamide arm: synthesis, crystal structure, computational studies and inhibitory activity against carbonic anhydrase I, II, and IX isoforms†.
Aimene Y; Eychenne R; Mallet-Ladeira S; Saffon N; Winum JY; Nocentini A; Supuran CT; Benoist E; Seridi A
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):773-782. PubMed ID: 30843736
[TBL] [Abstract][Full Text] [Related]
29. Novel sulfonamide-containing 2-indolinones that selectively inhibit tumor-associated alpha carbonic anhydrases.
Karalı N; Akdemir A; Göktaş F; Eraslan Elma P; Angeli A; Kızılırmak M; Supuran CT
Bioorg Med Chem; 2017 Jul; 25(14):3714-3718. PubMed ID: 28545816
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and carbonic anhydrase I, II, VII, and IX inhibition studies with a series of benzo[d]thiazole-5- and 6-sulfonamides.
Abdoli M; Angeli A; Bozdag M; Carta F; Kakanejadifard A; Saeidian H; Supuran CT
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1071-1078. PubMed ID: 28753093
[TBL] [Abstract][Full Text] [Related]
31. New anthranilic acid-incorporating N-benzenesulfonamidophthalimides as potent inhibitors of carbonic anhydrases I, II, IX, and XII: Synthesis, in vitro testing, and in silico assessment.
El-Azab AS; Abdel-Aziz AA; Bua S; Nocentini A; AlSaif NA; Almehizia AA; Alanazi MM; Hefnawy MM; Supuran CT
Eur J Med Chem; 2019 Nov; 181():111573. PubMed ID: 31394463
[TBL] [Abstract][Full Text] [Related]
32. Carbonic anhydrase inhibitors. Regioselective synthesis of novel 1-substituted 1,4-dihydro-4-oxo-3-pyridinesulfonamides and their inhibition of the human cytosolic isozymes I and II and transmembrane cancer-associated isozymes IX and XII.
Brzozowski Z; Sławiński J; Innocenti A; Supuran CT
Eur J Med Chem; 2010 Sep; 45(9):3656-61. PubMed ID: 20554082
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of novel 4-functionalized 1,5-diaryl-1,2,3-triazoles containing benzenesulfonamide moiety as carbonic anhydrase I, II, IV and IX inhibitors.
Vats L; Sharma V; Angeli A; Kumar R; Supuran CT; Sharma PK
Eur J Med Chem; 2018 Apr; 150():678-686. PubMed ID: 29571155
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of carbonic anhydrase isoforms I, II, IX and XII with novel Schiff bases: identification of selective inhibitors for the tumor-associated isoforms over the cytosolic ones.
Sarikaya B; Ceruso M; Carta F; Supuran CT
Bioorg Med Chem; 2014 Nov; 22(21):5883-90. PubMed ID: 25267005
[TBL] [Abstract][Full Text] [Related]
35. S-substituted 2-mercaptoquinazolin-4(3H)-one and 4-ethylbenzensulfonamides act as potent and selective human carbonic anhydrase IX and XII inhibitors.
El-Azab AS; Abdel-Aziz AA; Bua S; Nocentini A; AlSaif NA; Alanazi MM; El-Gendy MA; Ahmed HEA; Supuran CT
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):733-743. PubMed ID: 32189526
[TBL] [Abstract][Full Text] [Related]
36. Benzenesulfonamide bearing imidazothiadiazole and thiazolotriazole scaffolds as potent tumor associated human carbonic anhydrase IX and XII inhibitors.
Kumar R; Bua S; Ram S; Del Prete S; Capasso C; Supuran CT; Sharma PK
Bioorg Med Chem; 2017 Feb; 25(3):1286-1293. PubMed ID: 28065499
[TBL] [Abstract][Full Text] [Related]
37. Carbonic anhydrase inhibitors. Inhibition of the cytosolic and tumor-associated carbonic anhydrase isozymes I, II, and IX with a series of 1,3,4-thiadiazole- and 1,2,4-triazole-thiols.
Almajan GL; Innocenti A; Puccetti L; Manole G; Barbuceanu S; Saramet I; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 May; 15(9):2347-52. PubMed ID: 15837323
[TBL] [Abstract][Full Text] [Related]
38. Effects of dopaminergic compounds on carbonic anhydrase isozymes I, II, and VI.
Sentürk M; Ekinci D; Göksu S; Supuran CT
J Enzyme Inhib Med Chem; 2012 Jun; 27(3):365-9. PubMed ID: 21699374
[TBL] [Abstract][Full Text] [Related]
39. Fluorescent Silica Nanoparticles with Multivalent Inhibitory Effects towards Carbonic Anhydrases.
Touisni N; Kanfar N; Ulrich S; Dumy P; Supuran CT; Mehdi A; Winum JY
Chemistry; 2015 Jul; 21(29):10306-9. PubMed ID: 25965260
[TBL] [Abstract][Full Text] [Related]
40. The impact of hydroquinone on acetylcholine esterase and certain human carbonic anhydrase isoenzymes (hCA I, II, IX, and XII).
Scozzafava A; Kalın P; Supuran CT; Gülçin İ; Alwasel SH
J Enzyme Inhib Med Chem; 2015 Dec; 30(6):941-6. PubMed ID: 25586344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
